FDA.reportPublic FDA data

Zeposia 0.92 MG Oral Capsule

RxCUI
2288412
RxNorm name
Zeposia 0.92 MG Oral Capsule
Display name
Zeposia 0.92 MG Oral Capsule
Full name
Zeposia 0.92 MG Oral Capsule
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:09

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ZEPOSIA 7-Day Starter PackOZANIMOD HYDROCHLORIDECelgene Corporation93ce2fab-edfb-4804-8074-963071de51e42026-04-16Warnings, Adverse reactionsExact identifier
rxcui: 2288412

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
93ce2fab-edfb-4804-8074-963071de51e4ZEPOSIA 0.92 MG Oral Capsule [PSN] · ozanimod 0.92 MG Oral Capsule [Zeposia] [SBD] · Zeposia 0.92 MG Oral Capsule [SY]325These highlights do not include all the information needed to use ZEPOSIA safely and effectively. See full prescribing information for ZEPOSIA. ZEPOSIA ® (ozanimod) capsules, for oral use Initial U.S. Approval: 202020260416